ARTICLE | Company News
Anacor sales and marketing update
September 29, 2014 7:00 AM UTC
Anacor said the Sandoz Inc. generics unit of Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland) launched Kerydin tavaborole in the U.S. to treat onychomycosis of the toenails. FDA approved the top...